Skip to Content

Embecta Corp EMBC

Morningstar Rating
$13.89 −0.27 (1.91%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EMBC is trading at a 31% discount.
Price
$14.26
Fair Value
$28.21
Uncertainty
Very High
1-Star Price
$88.92
5-Star Price
$84.86
Economic Moat
Lnhxxx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EMBC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$14.16
Day Range
$13.8714.23
52-Week Range
$12.7233.07
Bid/Ask
$13.82 / $14.84
Market Cap
$799.77 Mil
Volume/Avg
251,739 / 492,656

Key Statistics

Price/Earnings (Normalized)
4.41
Price/Sales
0.72
Dividend Yield (Trailing)
4.32%
Dividend Yield (Forward)
4.32%
Total Yield
4.32%

Company Profile

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Value
Total Number of Employees
2,200

Comparables

Valuation

Metric
EMBC
LUNG
OM
Price/Earnings (Normalized)
4.41
Price/Book Value
3.011.24
Price/Sales
0.725.111.15
Price/Cash Flow
6.88
Price/Earnings
EMBC
LUNG
OM

Financial Strength

Metric
EMBC
LUNG
OM
Quick Ratio
1.555.624.27
Current Ratio
2.206.505.26
Interest Coverage
1.59−19.37−13.39
Quick Ratio
EMBC
LUNG
OM

Profitability

Metric
EMBC
LUNG
OM
Return on Assets (Normalized)
12.52%−22.61%−39.03%
Return on Equity (Normalized)
−31.80%−72.89%
Return on Invested Capital (Normalized)
30.00%−25.75%−44.98%
Return on Assets
EMBC
LUNG
OM
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncWxdlv$141.1 Bil
BDX
Becton Dickinson & CoScrxyd$68.1 Bil
ALC
Alcon IncBgqkrt$42.4 Bil
CLPBY
Coloplast A/S ADRFkwqm$29.9 Bil
RMD
ResMed IncBhmhbkg$26.6 Bil
WST
West Pharmaceutical Services IncLsmd$26.3 Bil
BAX
Baxter International IncQtlqsvp$21.6 Bil
COO
The Cooper Companies IncLsdlvs$20.4 Bil
HOLX
Hologic IncVtcvrp$17.5 Bil
TFX
Teleflex IncZmdt$10.6 Bil

Sponsor Center